Clinical Trial Update: Expanded Access Program for R007 (Probucol) Tablets in Adults With Mitochondrial Disease and Chronic Kidney Disease

View source ↗

Summary

RiboNova Inc. has announced an expanded access program for R007 (Probucol) tablets in adults with mitochondrial disease and chronic kidney disease, and the prog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Mitochondrial Disease

Drugs mentioned

• R007 (Probucol) (Probucol)

Snippet

Sponsor: RiboNova Inc. | Conditions: Mitochondrial Disease, Chronic Kidney Disease | Status: AVAILABLE